MTCM
EIDX

Mint Tower Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Mint Tower Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-270
Closed – – 469
2020
Q4 		$0 Buy
+270
New +$23.9K ﹤0.01% 390

Mint Tower Capital Management's EIDX Position: Q1 2021 in Review

Mint Tower Capital Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 270 shares.

Mint Tower Capital Management first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Mint Tower Capital Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 270 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021.
  • Mint Tower Capital Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Mint Tower Capital Management's Eidos Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Mint Tower Capital Management's 13F filing for Q1 2021, filed 12 May 2021.